Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

Graft-versus-host disease (GVHD) is uniformly lethal in recipients of HLA-mismatched marrow. In patients with severe combined immunodeficiency disease, this major obstacle can be overcome by rigorous T-cell depletion before transplantation. In leukaemia patients, however, the benefit of preventing GVHD is offset by graft rejection or graft failure. Very recently, this problem was overcome by supplementing T cell-depleted bone marrow transplants with megadoses of peripheral blood stem cells collected by leukapheresis after mobilization of the donor stem cells with granulocyte colony-stimulating factor (G-CSF). In the present study, we further demonstrate in a mouse model (C57BL/6C3H/HeJ) that escalation of bone marrow doses by four- to fivefold leads to full donor-type chimerism in sublethally irradiated (6.5 Gy) recipients. Thus, the new source of G-CSF mobilized human haematopoietic stem cells may enable extending the use of mismatched bone marrow transplants to patients with non-malignant diseases for whom supralethal conditioning is not a prerequisite.

1. Reisner, Y. et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow Cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61, 341−348 (1983). | PubMed  | ISI | ChemPort |
2. Gale, R.P. & Reisner, Y. Graft rejection and graft-versus-host-disease: Mirror images. Lancet i, 1468−1470 (1986).
3. Gengozian, N., Carlson, D.E. & Allen, E.M. Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure rates. Transplantation 7, 259−273 (1969). | PubMed  | ISI | ChemPort |
4. Vriesendorp, H.M. Engraftment of hemopoietic cells. in Bone Marrow Transplantation: Biological Mechanisms and Clinical Practice (ed. Lowenberg, D. W. & van Bekkum, B.) 73−145 (Dekker, New York, 1985).
5. Lapidot, T., Terenzi, A., Singer, T.S. & Reisner, Y. Size of bone marrow inoculum versus number of donor-type cells used for presensitization: a murine model for bone marrow allograft rejection in leukemia patients. Blood 70, 309a (1987).
6. Lapidot, T., Terenzi, A., Singer, T.S., Salomon, O. & Reisner, Y. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 73, 2025−2032 (1989). | PubMed  | ISI | ChemPort |
7. Soderling, C.C., Song, C.W., Blazer, B.R. & Vallera, D.A. A correlation between conditioning and engraftment in recipients of MHC mismatched T cell-depleted murine bone marrow transplants. Immunology 135, 941−946 (1985). | ChemPort |
8. Ferrara, J., Lipton, J., Hellman, S., Burakoff, S. & Mauch, P. Engraftment following T cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers. Transplantation 43, 461−467 (1987). | PubMed  | ISI | ChemPort |
9. Uharek, L. et al. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 79, 1612−1621 (1992). | PubMed  | ISI | ChemPort |
10. Gianni, A.M. et al. Granulocyte-macrophage colony stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet ii, 580−585 (1989). | Article |
11. Aversa, F. et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84, 3948−3955 (1994). | PubMed  | ISI | ChemPort |
12. Lapidot, T., Lubin, I., Faktorowich, Y., Erlich, P. & Reisner, Y. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc. natn. Acad. Sci. U.S.A. 87, 4595−4599 (1990). | ChemPort |
13. Martin, P.J. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J. exp. Med. 178, 703−712 (1993). | PubMed  | ISI | ChemPort |
14. Sykes, M., Sheard, M. & Sachs, D.H. Effects of T Cell depletion in radiation bone marrow chimers. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD. J. Immun. 141, 2282−2288 (1988). | PubMed  | ISI | ChemPort |
15. Navarro, J. & Touraine, J.-L. Promotion of fetal liver engraftment by T-cells in a murine semiallogeneic model without graft-versus-host reaction. Transplantation 47, 871−876 (1989). | PubMed  | ISI | ChemPort |
16. Faktorowich, Y., Lapidot, T., Lubin, I. & Reisner, Y. Enhancement of BM allo-grafting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-C3H/HeJ) and (C3H/HeJC57BL/6) chimeras. Bone Marrow Transplant. 12, 15−20 (1993). | PubMed  | ISI | ChemPort |
17. Slavin, S., Strober, S., Fuks, Z. & Kaplan, H.S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid iradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J. exp. Med. 146, 34−48 (1977). | PubMed  | ISI | ChemPort |
18. Pierce, G. & Watts, L. The role of donor lymphoid cells in the transfer of allograft tolerance. Transplantation 40, 702−707 (1985). | PubMed  | ISI | ChemPort |
19. Cobbold, S., Martin, G. & Qin, S. & Waldmann, H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323, 164−166 (1986). | PubMed  | ISI | ChemPort |
20. Sharabi, Y. & Sachs, D. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. exp. Med. 169, 493−502 (1989). | PubMed  | ISI | ChemPort |
21. Mayumi, H. & Good, R. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance — inducing method using cyclophosphamide. J. exp. Med. 169, 213−238 (1989). | PubMed  | ISI | ChemPort |
22. Qin, S., Cobbold, S., Benjamin, R. & Waldmann, H. Induction of classical transplantation tolerance in the adult. J. exp. Med. 169, 779−794 (1989). | PubMed  | ISI | ChemPort |
23. Leong, L., Qin, S., Cobbold, S. & Waldmann, H. Classical transplantation tolerance in the adult: The interaction between myeloablation and immunosuppretion. Eur. J. Immun. 22, 2825−2830 (1992). | ISI | ChemPort |
24. Pierce, G.E. & Watts, L.M. Do donor cells function as veto cells in the induction and maintenance of tolerance across an MHC disparity in mixed lymphoid radiation chimeras? Transplantation 55, 882−887 (1993). | PubMed  | ISI | ChemPort |
25. Pierce, G.E. & Watts, L.M. Thy 1+ donor cells function as veto cells in the maintenance of tolerance across a major histocompatibility complex disparity in mixed-lymphoid radiation chimeras. Transplantn Proc. 25, 331−333 (1993). | ChemPort |
26. Kiyoshi, H., Nakamura, H., Henkart, P. & Gress, R. Clonal deletion of post-thymic T cells: Veto cells kill precursor cytotoxic T lymphocytes. J. exp. Med. 175, 863−868 (1992). | PubMed  | ISI | ChemPort |
27. Tscherning, T. & Claesson, M. Veto-like down regulation of T helper cell reactivity in vivo by injection of semi-allogeneic spleen cells. Immunology Lett. 29, 223−228 (1991). | Article | ISI | ChemPort |
28. Kikuya, S., Inaba, M., Ogata, H., Yasumizu, R. & Inaba, K. Wheat germ agglutinin-positive cells in a stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc. natn. Acad. Sci. U.S.A. 85, 4824−4826 (1988).
29. Strober, S., Palathumpat, V., Schwadron, R. & Hertel-Wulff, B. Cloned natural suppressor cells prevent lethal graft-vs-host disease. J. Immun. 138, 699−703 (1987). | PubMed  | ISI | ChemPort |
30. Kaufman, C.L. et al. Phenotypic characterization of a novel bone marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84, 2436−2446 (1994). | PubMed  | ISI | ChemPort |
31. Ramsdell, F. & Fowlkes, B. Maintenance of in vivo tolerance by persistence of antigen. Science 257, 1130−1134 (1992). | PubMed  | ISI | ChemPort |
32. Rocha, B., Tanchot, C. & Von Boehmer, H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. exp. Med. 177, 1517−1521 (1993). | PubMed  | ISI | ChemPort |
33. Reisner, Y., Itzicovitch, L., Meshorer, A. & Sharon, N. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc. natn. Acad. Sci. U.S.A. 75, 2933−2936 (1978). | ChemPort |
34. Schwartz, E., Lapidot, T., Gozes, D., Singer, T.S. & Reisner, Y. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T-cells and alloreactive cytotoxic precursors. J. Immun. 138, 460−465 (1987). | PubMed  | ISI | ChemPort |
35. Ryser, J.E. & MacDonald, H.R. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J. Immun. 122, 1691−1696 (1979). | PubMed  | ISI | ChemPort |

	Top

	Top